AbbVie Lowers Full-Year EPS Guidance by $0.17 Due to Q2 IPR&D Expenses
ABBV sits 38% above its 52-week low of $184.63.
Summary
AbbVie updated its 2026 full-year and Q2 adjusted diluted EPS guidance, lowering it by $0.17 per share due to acquired IPR&D and milestones expenses incurred in the second quarter.
Key Events · Earnings and Guidance · ABBV
-
Revised Full-Year EPS Guidance
AbbVie's full-year 2026 adjusted diluted EPS guidance range is now $13.91 - $14.11, down from the previously announced $14.08 - $14.28.
-
Q2 IPR&D and Milestones Expense
The company expects to include $291 million in acquired IPR&D and milestones expense for the second quarter of 2026, representing an unfavorable impact of $0.17 per share.
-
Updated Q2 EPS Guidance
The second-quarter 2026 adjusted diluted EPS guidance range, including the IPR&D impact, is $3.57 - $3.61.
Analysis · ABBV · Life Sciences
AbbVie has revised its full-year and second-quarter adjusted diluted EPS guidance downwards due to $291 million in acquired IPR&D and milestones expense. This reduction, while stemming from R&D investments, directly impacts near-term profitability expectations and follows the recent announcement of the Apogee Therapeutics acquisition, which could be a source of such expenses. Investors will be watching how these expenses affect future earnings and the company's overall financial outlook.
How filings like this one have moved
In the 30 days to Oct 4, 2026, 29.2% of the 1581 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.60%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ABBV was trading at $255.50 on NYSE in the Life Sciences sector, with a market capitalization of approximately $450.1B. The 52-week trading range was $184.63 to $261.64. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.